Ultramicrosize Griseofulvin
Active substance: griseofulvin
TABLET · GRISEOFULVIN 250 mg/1
United StatesActive
Marketing holder: Sigmapharm Laboratories, LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- GRISEOFULVIN · 250 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-3dd2-73b1-91b2-cf29363e8411,01a1208c-abea-7cd2-80e1-7baa781ab752,01a1208c-e857-782c-851b-a8d1cd9b3565,01a1208d-0631-7876-85ff-047ba045b44f,01a1208d-179e-7eeb-9798-1673db42cbf2;count=21 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 42794-014
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 42794-014 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 42794-014 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 42794-014 · Verified 2026-10-09 · open in source